UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

Participants in this study have been diagnosed with a type of bone cancer called chondrosarcoma that has spread to other parts of the body or is not able to be removed with surgery. In this study, all subjects will receive the drug pazopanib. This research study is being performed at about 5 clinics across the US. Approximately 47 subjects will take part in this study.

Start Date
September 5, 2012
End Date
September 5, 2022
Gender Preference
Age Group
18 - 99 years
Principal Investigator
Mohammed Milhem, MD
Contact Info

Mohammed Milhem, 319-356-2324

Bone Cancer ; Cancer ; Chondrosarcoma ; Connective Tissue ; Metastatic Chondrosarcoma ; Milhem ; Neoplasms ; Pazopanib ; Phase 2 ; Phase II ; Sarcoma ; Soft Tissue ; Surgically Unresectable Chondrosarcoma ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.